10 Biotech Buys from Credit Suisse

Which biotech stocks are buys in 2016? Alethia Young, the new biotech analyst at Credit Suisse, weighed in with her calls on the industry, launching coverage on 14 stocks of which 10 were rated at outperform, including Gilead (GILD), Amgen (AMGN), Celgene (CELG) and Biomarin (BMRN). Biogen (BIIB) and Regeneron (REGN), however, were launched with […]